Related Experiment Video
Updated: Dec 9, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.2K
A Model-Based Insulin Dose Optimization Algorithm for People With Type 1 Diabetes on Multiple Daily Injections
IEEE Transactions on Bio-Medical Engineering
|September 11, 2020
Summary
A new algorithm optimizes insulin doses for type 1 diabetes (T1D) management using multiple daily injections (MDI). This approach improves glycemic control by analyzing glucose, insulin, and meal data for better insulin dosing recommendations.
Area of Science:
- Biomedical Engineering
- Computational Biology
- Endocrinology
Background:
- Type 1 diabetes (T1D) management commonly uses multiple daily injections (MDI) for insulin therapy.
- Achieving optimal glycemic control with MDI is challenging due to significant inter- and intra-individual variability in insulin response.
- Accurate insulin dosing is critical for preventing hyperglycemia and hypoglycemia in T1D patients.
Purpose of the Study:
- To develop and evaluate a novel model-based iterative algorithm for optimizing insulin doses in T1D patients on MDI therapy.
- To leverage previous-day glucose, insulin, and meal data for personalized insulin dose recommendations.
- To enhance the precision of insulin dosing to improve overall glycemic control.
Main Methods:
- A maximum-a-posteriori method was used to estimate parameters of a mathematical model for basal-bolus insulin effects.
- The algorithm integrates parameter estimates, confidence intervals, and goodness-of-fit metrics to generate updated insulin dose recommendations.
- The algorithm's performance was assessed using a 150-day clinical dataset, 60-day simulations, and a 6-day clinical experiment.
Main Results:
- The developed model demonstrated a good fit to clinical data, with a root-mean-square error of 1.75 mmol/L.
- Simulations showed a significant improvement in time spent within the target glucose range (64% to 77%).
- Hypoglycemia (time < 3.9 mmol/L) was reduced from 8.1% to 3.8%, and the algorithm proved feasible in a clinical setting.
Conclusions:
- The novel algorithm shows significant potential for improving glycemic control in individuals with T1D using MDI.
- This iterative, model-based approach offers a promising step towards advanced decision support systems for diabetes management.
- The findings suggest a pathway to enhance the quality of life for T1D patients through more precise insulin therapy.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
531
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
531
Insulin Formulations: Types and Delivery
530
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
530
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
111
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
111
Dosage Regimen: Individualization
97
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
97
Dosage Regimens: Designs and Approaches
163
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
163
Diabetes Mellitus: Overview and Type I Subtype
4.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.6K

